Department of Digestive, Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Henri Mondor University Hospital, APHP, University Paris Est, UPEC, Creteil, France.
Department of Hepatobiliary Surgery and Liver Transplantation, Beaujon Hospital, University Hospitals Paris Nord Val de Seine, Clichy, France.
Transpl Int. 2018 Feb;31(2):131-151. doi: 10.1111/tri.13089. Epub 2017 Nov 16.
Anastomotic biliary strictures (ABSs) occur in up to 15% of patients after liver transplantation (LT). The aim of this study was to compare the efficacy and safety of self-expandable metal stents (SEMS) versus multiple plastic stents (MPS). Databases were searched through April 2017. The outcome measures were technical success, stricture resolution, recurrence and complications. We synthesized the findings descriptively and performed a meta-analysis. Three randomized controlled trials and one retrospective cohort study were identified, including 179 MPS and 119 SEMS patients. Outcome data were pooled in a meta-analysis that showed an advantage of SEMS in terms of the number of ERCP procedures (mean difference: 1.69 ERCP; 95% CI, 1-2.39; P < 0.00001) and treatment days (mean difference: 40.2 days; 95% CI, 3.9-76.4; P = 0.03), with no differences in terms of ABS resolution or recurrence. Fourteen case series reported MPS outcomes and fifteen reported SEMS outcomes, including 647 and 419 patients, respectively. Based on low-quality evidence, we cannot draw any reliable conclusions on the superiority of MPS or SEMS strategies. Even though shorter treatment times and fewer ERCP procedures support the use of SEMS, whether one technique has well-defined advantages over the other remains unclear.
吻合口胆管狭窄(ABS)在肝移植(LT)后高达 15%的患者中发生。本研究旨在比较自膨式金属支架(SEMS)与多个塑料支架(MPS)的疗效和安全性。通过 2017 年 4 月检索数据库。主要转归指标为技术成功率、狭窄缓解率、复发和并发症。我们采用描述性方法综合研究结果,并进行荟萃分析。共确定了 3 项随机对照试验和 1 项回顾性队列研究,包括 179 例 MPS 和 119 例 SEMS 患者。在荟萃分析中汇总了结局数据,结果显示 SEMS 在 ERCP 次数(均数差:1.69 次;95%CI,1-2.39;P<0.00001)和治疗天数(均数差:40.2 天;95%CI,3.9-76.4;P=0.03)方面具有优势,但 ABS 缓解率或复发率无差异。14 项病例系列报告了 MPS 结果,15 项报告了 SEMS 结果,分别包括 647 例和 419 例患者。基于低质量证据,我们不能得出关于 MPS 或 SEMS 策略优势的任何可靠结论。尽管较短的治疗时间和较少的 ERCP 次数支持使用 SEMS,但一种技术是否比另一种具有明确优势仍不清楚。